Last 12 months
Inside the activity.
0 purchase rows · 29 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 9 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 23, 2021 Filed Feb 25, 2021 21:36 UTC |
Deppe Michael JVP, Corp. Controller & CAO
|
Tax withholdingCommon Stock | 159 | $121.15 | $19,262.85 |
DisclosureSEC source: 0001022079-21-000042 · wf-form4_161428895318755.xml · nonDerivative · entry 1 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,704 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of previous grants of restricted shares. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 21:39 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
Tax withholdingCommon Stock | 693 | $121.15 | $83,956.95 |
DisclosureSEC source: 0001022079-21-000043 · wf-form4_161428913031496.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,596 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of previous grants of restricted shares. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 21:34 UTC |
EGLINTON MANNER CARRIESVP, Advanced Diagnostics
|
Tax withholdingCommon Stock | 1,017 | $121.15 | $123,209.55 |
DisclosureSEC source: 0001022079-21-000041 · wf-form4_161428886233481.xml · nonDerivative · entry 1 EGLINTON MANNER CARRIE · CIK 0001696776 · SVP, Advanced Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,824 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of previous grants of restricted shares. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 21:31 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, CEO and President
|
Tax withholdingCommon Stock | 4,033 | $121.15 | $488,597.95 |
DisclosureSEC source: 0001022079-21-000039 · wf-form4_161428867883226.xml · nonDerivative · entry 1 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,265 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of previous grants of restricted share units. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 21:32 UTC |
GUINAN MARKExecutive Vice President & CFO
|
Tax withholdingCommon Stock | 830 | $121.15 | $100,554.50 |
DisclosureSEC source: 0001022079-21-000040 · wf-form4_161428874135843.xml · nonDerivative · entry 1 GUINAN MARK · CIK 0001505998 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,414 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of previous grants of restricted share units. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 21:30 UTC |
Doherty Catherine T.SVP, Group Exec. Clin. Fran.
|
Tax withholdingCommon Stock | 796 | $121.15 | $96,435.40 |
DisclosureSEC source: 0001022079-21-000038 · wf-form4_161428858488018.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,556 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of previous grants of restricted share units. Read SEC document |
| February 17, 2021 Filed Feb 20, 2021 01:47 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, CEO and President
|
GrantNon-Qualifed Stock Option (right to buy) · Derivative | 120,901 | $0.00 Strike: $121.81 | $0.00 |
DisclosureSEC source: 0001022079-21-000025 · wf-form4_161378565309991.xml · derivative · entry 2 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,901 Underlying: Common Stock · 120,901 shares Expires 2031-02-17 F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 17, 2021 Filed Feb 20, 2021 01:47 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, CEO and President
|
GrantCommon Stock | 21,551 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-21-000025 · wf-form4_161378565309991.xml · nonDerivative · entry 1 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,298 F1 · security: Represents an award of restricted share units. Read SEC document |
| February 17, 2021 Filed Feb 20, 2021 01:44 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
GrantNon-Qualifed Stock Option (right to buy) · Derivative | 17,958 | $0.00 Strike: $121.81 | $0.00 |
DisclosureSEC source: 0001022079-21-000023 · wf-form4_161378547899874.xml · derivative · entry 3 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,958 Underlying: Common Stock · 17,958 shares Expires 2031-02-17 F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 17, 2021 Filed Feb 20, 2021 01:44 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
GrantCommon Stock | 3,202 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-21-000023 · wf-form4_161378547899874.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,289 Read SEC document |
| February 17, 2021 Filed Feb 20, 2021 01:41 UTC |
Deppe Michael JVP, Corp. Controller & CAO
|
GrantNon-Qualifed Stock Option (right to buy) · Derivative | 4,003 | $0.00 Strike: $121.81 | $0.00 |
DisclosureSEC source: 0001022079-21-000021 · wf-form4_161378529998296.xml · derivative · entry 3 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,003 Underlying: Common Stock · 4,003 shares Expires 2031-02-17 F5 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 17, 2021 Filed Feb 20, 2021 01:41 UTC |
Deppe Michael JVP, Corp. Controller & CAO
|
GrantCommon Stock | 715 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-21-000021 · wf-form4_161378529998296.xml · nonDerivative · entry 1 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,863 F1 · security: Represents an award of restricted share units. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. F3 · balance_after: The amount includes approximately 53 shares acquired via dividend reinvestment since the date of the last filing on Form 4 pursuant to a dividend reinvestment plan, sponsored by a broker-dealer, that essentially mirrors a dividend reinvestment plan sponsored by the registrant. Read SEC document |
| February 17, 2021 Filed Feb 20, 2021 01:36 UTC |
GUINAN MARKExecutive Vice President & CFO
|
GrantNon-Qualifed Stock Option (right to buy) · Derivative | 31,774 | $0.00 Strike: $121.81 | $0.00 |
DisclosureSEC source: 0001022079-21-000019 · wf-form4_161378500022070.xml · derivative · entry 2 GUINAN MARK · CIK 0001505998 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,774 Underlying: Common Stock · 31,774 shares Expires 2031-02-17 F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 17, 2021 Filed Feb 20, 2021 01:36 UTC |
GUINAN MARKExecutive Vice President & CFO
|
GrantCommon Stock | 5,665 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-21-000019 · wf-form4_161378500022070.xml · nonDerivative · entry 1 GUINAN MARK · CIK 0001505998 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,244 F1 · security: Represents an award of restricted share units. Read SEC document |
| February 17, 2021 Filed Feb 20, 2021 01:33 UTC |
Doherty Catherine T.SVP, Group Exec. Clin. Fran.
|
GrantNon-Qualifed Stock Option (right to buy) · Derivative | 22,105 | $0.00 Strike: $121.81 | $0.00 |
DisclosureSEC source: 0001022079-21-000017 · wf-form4_161378478948480.xml · derivative · entry 3 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,105 Underlying: Common Stock · 22,105 shares Expires 2031-02-17 F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 17, 2021 Filed Feb 20, 2021 01:33 UTC |
Doherty Catherine T.SVP, Group Exec. Clin. Fran.
|
GrantCommon Stock | 3,941 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-21-000017 · wf-form4_161378478948480.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,352 F1 · security: Represents an award of restricted share units. Read SEC document |
| February 17, 2021 Filed Feb 20, 2021 01:30 UTC |
Davis J. E.EVP, General Diagnostics
|
GrantNon-Qualifed Stock Option (right to buy) · Derivative | 31,774 | $0.00 Strike: $121.81 | $0.00 |
DisclosureSEC source: 0001022079-21-000015 · wf-form4_161378461299805.xml · derivative · entry 2 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,774 Underlying: Common Stock · 31,774 shares Expires 2031-02-17 F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 17, 2021 Filed Feb 20, 2021 01:30 UTC |
Davis J. E.EVP, General Diagnostics
|
GrantCommon Stock | 5,665 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-21-000015 · wf-form4_161378461299805.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,751 F1 · security: Represents an award of restricted share units. Read SEC document |
| February 17, 2021 Filed Feb 20, 2021 01:27 UTC |
EGLINTON MANNER CARRIESVP, Advanced Diagnostics
|
GrantNon-Qualifed Stock Option (right to buy) · Derivative | 27,633 | $0.00 Strike: $121.81 | $0.00 |
DisclosureSEC source: 0001022079-21-000013 · wf-form4_161378444224200.xml · derivative · entry 2 EGLINTON MANNER CARRIE · CIK 0001696776 · SVP, Advanced Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,633 Underlying: Common Stock · 27,633 shares Expires 2031-02-17 F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 17, 2021 Filed Feb 20, 2021 01:27 UTC |
EGLINTON MANNER CARRIESVP, Advanced Diagnostics
|
GrantCommon Stock | 4,926 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-21-000013 · wf-form4_161378444224200.xml · nonDerivative · entry 1 EGLINTON MANNER CARRIE · CIK 0001696776 · SVP, Advanced Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,841 F1 · security: Represents an award of restricted share units. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| February 17, 2021 Filed Feb 22, 2021 21:50 UTC |
Mendez Manuel O.SVP & Chief Commercial Officer
|
GrantNon-Qualifed Stock Option (right to buy) · Derivative | 27,633 | $0.00 Strike: $121.81 | $0.00 |
DisclosureSEC source: 0001022079-21-000030 · wf-form4_161403060246936.xml · derivative · entry 2 Mendez Manuel O. · CIK 0001475995 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,633 Underlying: Common Stock · 27,633 shares Expires 2031-02-17 F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 17, 2021 Filed Feb 22, 2021 21:50 UTC |
Mendez Manuel O.SVP & Chief Commercial Officer
|
GrantCommon Stock | 4,926 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-21-000030 · wf-form4_161403060246936.xml · nonDerivative · entry 1 Mendez Manuel O. · CIK 0001475995 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,045 F1 · security: Represents an award of restricted share units. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| January 04, 2021 Filed Jan 7, 2021 13:20 UTC |
RING TIMOTHY MDirector
|
GrantPhantom Stock Units · Derivative | 264 | $119.93 Strike: $0.00 | $31,662.31 |
DisclosureSEC source: 0001022079-21-000004 · wf-form4_161002559884422.xml · derivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,313.001 Underlying: Common Stock · 264 shares Expires not disclosed F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F2 · balance_after: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11. Read SEC document |
| January 04, 2021 Filed Jan 7, 2021 13:18 UTC |
EGLINTON MANNER CARRIESVP, Advanced Diagnostics
|
Tax withholdingCommon Stock | 2,640 | $119.00 | $314,160.00 |
DisclosureSEC source: 0001022079-21-000002 · wf-form4_161002546685283.xml · nonDerivative · entry 1 EGLINTON MANNER CARRIE · CIK 0001696776 · SVP, Advanced Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,896 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| December 24, 2020 Filed Dec 28, 2020 21:27 UTC |
GUINAN MARKExecutive Vice President & CFO
|
Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 81,756 | $66.51 Strike: $66.51 | $5,437,591.56 |
DisclosureSEC source: 0001022079-20-000200 · wf-form4_160919082499081.xml · derivative · entry 4 GUINAN MARK · CIK 0001505998 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 81,756 shares Expires 2026-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 23, 2020. F4 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 25, 2017, the second on February 25, 2018 and the final on February 25, 2019. Read SEC document |
| December 24, 2020 Filed Dec 28, 2020 21:27 UTC |
GUINAN MARKExecutive Vice President & CFO
|
SaleCommon Stock | 22,563 | $121.18 | $2,734,139.21 |
DisclosureSEC source: 0001022079-20-000200 · wf-form4_160919082499081.xml · nonDerivative · entry 3 GUINAN MARK · CIK 0001505998 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,579 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 23, 2020. F3 · price: This transaction was executed in multiple trades at prices ranging from $120.64 to $121.58. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 24, 2020 Filed Dec 28, 2020 21:27 UTC |
GUINAN MARKExecutive Vice President & CFO
|
SaleCommon Stock | 59,193 | $120.06 | $7,106,534.00 |
DisclosureSEC source: 0001022079-20-000200 · wf-form4_160919082499081.xml · nonDerivative · entry 2 GUINAN MARK · CIK 0001505998 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,142 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 23, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $119.64 to $120.63. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 24, 2020 Filed Dec 28, 2020 21:27 UTC |
GUINAN MARKExecutive Vice President & CFO
|
Exercise / conversionCommon Stock | 81,756 | $66.51 | $5,437,591.56 |
DisclosureSEC source: 0001022079-20-000200 · wf-form4_160919082499081.xml · nonDerivative · entry 1 GUINAN MARK · CIK 0001505998 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,335 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 23, 2020. Read SEC document |
| November 24, 2020 Filed Nov 27, 2020 16:38 UTC |
WILENSKY GAIL RDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 6,111 | $57.67 Strike: $57.67 | $352,390.82 |
DisclosureSEC source: 0001022079-20-000194 · wf-form4_160651310284414.xml · derivative · entry 4 WILENSKY GAIL R · CIK 0001018538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,111 shares Expires 2021-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options vested in three equal annual installments beginning with the first on May 17, 2012, the second on May 17, 2013 and the final on May 17, 2014. Read SEC document |
| November 24, 2020 Filed Nov 27, 2020 16:38 UTC |
WILENSKY GAIL RDirector
|
SaleCommon Stock | 6,111 | $126.02 | $770,120.44 |
DisclosureSEC source: 0001022079-20-000194 · wf-form4_160651310284414.xml · nonDerivative · entry 2 WILENSKY GAIL R · CIK 0001018538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,482 F1 · price: This transaction was executed in multiple trades at prices ranging from $125.93 to $126.17. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 24, 2020 Filed Nov 27, 2020 16:38 UTC |
WILENSKY GAIL RDirector
|
Exercise / conversionCommon Stock | 6,111 | $57.67 | $352,390.82 |
DisclosureSEC source: 0001022079-20-000194 · wf-form4_160651310284414.xml · nonDerivative · entry 1 WILENSKY GAIL R · CIK 0001018538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,593 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 23, 2020 Filed Nov 24, 2020 21:31 UTC |
STANZIONE DANIELDirector
|
SaleCommon Stock | 2,300 | $127.45 | $293,136.84 |
DisclosureSEC source: 0001022079-20-000192 · wf-form4_160625345488945.xml · nonDerivative · entry 3 STANZIONE DANIEL · CIK 0001221534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,349 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 23, 2020. F4 · price: This transaction was executed in multiple trades at prices ranging from $127.12 to $127.88. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 23, 2020 Filed Nov 24, 2020 21:31 UTC |
STANZIONE DANIELDirector
|
SaleCommon Stock | 3,302 | $126.46 | $417,583.80 |
DisclosureSEC source: 0001022079-20-000192 · wf-form4_160625345488945.xml · nonDerivative · entry 2 STANZIONE DANIEL · CIK 0001221534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,649 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 23, 2020. F3 · price: This transaction was executed in multiple trades at prices ranging from $126.09 to $127.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 23, 2020 Filed Nov 24, 2020 21:31 UTC |
STANZIONE DANIELDirector
|
SaleCommon Stock | 5,621 | $125.73 | $706,737.89 |
DisclosureSEC source: 0001022079-20-000192 · wf-form4_160625345488945.xml · nonDerivative · entry 1 STANZIONE DANIEL · CIK 0001221534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,951 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 23, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $125.09 to $126.04. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 21, 2020 Filed Oct 23, 2020 20:42 UTC |
Deppe Michael JVP, Corp. Controller & CAO
|
Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 5,700 | $57.61 Strike: $57.61 | $328,348.50 |
DisclosureSEC source: 0001022079-20-000186 · wf-form4_160348572710096.xml · derivative · entry 7 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,700 shares Expires 2022-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 10, 2020. F6 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 27, 2013, the second on February 27, 2014 and the final on February 27, 2015. Read SEC document |
| October 21, 2020 Filed Oct 23, 2020 20:42 UTC |
Deppe Michael JVP, Corp. Controller & CAO
|
Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 4,750 | $56.82 Strike: $56.82 | $269,895.00 |
DisclosureSEC source: 0001022079-20-000186 · wf-form4_160348572710096.xml · derivative · entry 6 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,750 shares Expires 2021-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 10, 2020. F5 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 15, 2012, the second on February 15, 2013 and the final on February 15, 2014. Read SEC document |
| October 21, 2020 Filed Oct 23, 2020 20:42 UTC |
Deppe Michael JVP, Corp. Controller & CAO
|
SaleCommon Stock | 4,750 | $125.00 | $593,750.00 |
DisclosureSEC source: 0001022079-20-000186 · wf-form4_160348572710096.xml · nonDerivative · entry 4 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,090 F2 · balance_after: The amount includes approximately 46 shares acquired via dividend reinvestment since the date of the last filing on Form 4 pursuant to a dividend reinvestment plan, sponsored by a broker-dealer, that essentially mirrors a dividend reinvestment plan sponsored by the registrant. F3 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| October 21, 2020 Filed Oct 23, 2020 20:42 UTC |
Deppe Michael JVP, Corp. Controller & CAO
|
SaleCommon Stock | 5,700 | $125.00 | $712,500.00 |
DisclosureSEC source: 0001022079-20-000186 · wf-form4_160348572710096.xml · nonDerivative · entry 3 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,785 Read SEC document |
| October 21, 2020 Filed Oct 23, 2020 20:42 UTC |
Deppe Michael JVP, Corp. Controller & CAO
|
Exercise / conversionCommon Stock | 5,700 | $57.61 | $328,348.50 |
DisclosureSEC source: 0001022079-20-000186 · wf-form4_160348572710096.xml · nonDerivative · entry 2 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,485 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 10, 2020. Read SEC document |
| October 21, 2020 Filed Oct 23, 2020 20:42 UTC |
Deppe Michael JVP, Corp. Controller & CAO
|
Exercise / conversionCommon Stock | 4,750 | $56.82 | $269,895.00 |
DisclosureSEC source: 0001022079-20-000186 · wf-form4_160348572710096.xml · nonDerivative · entry 1 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,785 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 10, 2020. Read SEC document |
| October 16, 2020 Filed Oct 19, 2020 20:17 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, CEO and President
|
Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 291,997 | $66.51 Strike: $66.51 | $19,420,720.47 |
DisclosureSEC source: 0001022079-20-000175 · wf-form4_160313862410575.xml · derivative · entry 3 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 291,997 shares Expires 2026-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on July 24, 2020. F2 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 25, 2017, the second on February 25, 2018 and the final on February 25, 2019. Read SEC document |
| October 16, 2020 Filed Oct 19, 2020 20:17 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, CEO and President
|
SaleCommon Stock | 291,997 | $120.00 | $35,039,640.00 |
DisclosureSEC source: 0001022079-20-000175 · wf-form4_160313862410575.xml · nonDerivative · entry 2 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,747 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on July 24, 2020. Read SEC document |
| October 16, 2020 Filed Oct 19, 2020 20:17 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, CEO and President
|
Exercise / conversionCommon Stock | 291,997 | $66.51 | $19,420,720.47 |
DisclosureSEC source: 0001022079-20-000175 · wf-form4_160313862410575.xml · nonDerivative · entry 1 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 529,744 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on July 24, 2020. Read SEC document |
| October 14, 2020 Filed Oct 15, 2020 20:45 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 35,591 | $52.17 Strike: $52.17 | $1,856,604.52 |
DisclosureSEC source: 0001022079-20-000173 · wf-form4_160279473370470.xml · derivative · entry 4 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,591 shares Expires 2024-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 31, 2020. F2 · derivative.exercise_date: The options vested in three equal annual installments beginning on the first on February 13, 2015, the second on February 13, 2016 and the final on February 13, 2017. Read SEC document |
| October 14, 2020 Filed Oct 15, 2020 20:45 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
SaleCommon Stock | 35,591 | $119.00 | $4,235,329.00 |
DisclosureSEC source: 0001022079-20-000173 · wf-form4_160279473370470.xml · nonDerivative · entry 2 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,087 F2 · kind: The options vested in three equal annual installments beginning on the first on February 13, 2015, the second on February 13, 2016 and the final on February 13, 2017. Read SEC document |
| October 14, 2020 Filed Oct 15, 2020 20:45 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
Exercise / conversionCommon Stock | 35,591 | $52.17 | $1,856,604.52 |
DisclosureSEC source: 0001022079-20-000173 · wf-form4_160279473370470.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,678 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 31, 2020. Read SEC document |
| October 06, 2020 Filed Oct 7, 2020 20:35 UTC |
Mendez Manuel O.SVP & Chief Commercial Officer
|
Tax withholdingCommon Stock | 5,871 | $114.01 | $669,352.71 |
DisclosureSEC source: 0001022079-20-000171 · wf-form4_160210293696290.xml · nonDerivative · entry 1 Mendez Manuel O. · CIK 0001475995 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,982 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 20:56 UTC |
RING TIMOTHY MDirector
|
GrantPhantom Stock Units · Derivative | 270 | $114.01 Strike: $0.00 | $30,782.70 |
DisclosureSEC source: 0001022079-20-000169 · wf-form4_160193133351771.xml · derivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,005.111 Underlying: Common Stock · 270 shares Expires not disclosed F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F2 · balance_after: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11. Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 20:18 UTC |
Doherty Catherine T.SVP, Group Exec. Clin. Fran.
|
Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 58,392 | $66.51 Strike: $66.51 | $3,883,651.92 |
DisclosureSEC source: 0001022079-20-000164 · wf-form4_159925068530041.xml · derivative · entry 5 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 58,392 shares Expires 2026-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2020. F5 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 25, 2017, the second on February 25, 2018 and the final on February 25, 2019. Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 20:18 UTC |
Doherty Catherine T.SVP, Group Exec. Clin. Fran.
|
SaleCommon Stock | 3,776 | $111.13 | $419,615.55 |
DisclosureSEC source: 0001022079-20-000164 · wf-form4_159925068530041.xml · nonDerivative · entry 3 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,411 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2020. F3 · price: This transaction was executed in multiple trades at prices ranging from $111.00 to $111.41. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.